UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Effect of Ceftaroline on Normal Human Intestinal Microflora

Antimicrobial Agents and Chemotherapy, 2010-05, Vol.54 (5), p.1811-1814

2010

Volltextzugriff (PDF)

Penetration of Ceftaroline into the Epithelial Lining Fluid of Healthy Adult Subjects

Antimicrobial agents and chemotherapy, 2016-10, Vol.60 (10), p.5849-5857

2016

Volltextzugriff (PDF)

Phase I study of the pharmacokinetics and safety of rezafungin in subjects with moderate/severe hepatic impairment and matched control subjects

Pharmacotherapy, 2024-06, Vol.44 (6), p.435-443

2024

Volltextzugriff (PDF)

679: Effect of Moderate Hepatic Impairment on the Safety and Pharmacokinetics of Rezafungin

Critical care medicine, 2021-01, Vol.49 (1), p.334-334

2021

Volltextzugriff (PDF)

Dalbavancin for the Treatment of Osteomyelitis in Adult Patients: A Randomized Clinical Trial of Efficacy and Safety

Open forum infectious diseases, 2019-01, Vol.6 (1), p.ofy331

2019

Volltextzugriff (PDF)

Current Use of Ceftaroline for Community-Acquired Bacterial Pneumonia (CABP) in US Hospitals: Length of Stay and Total Cost From the CAPTURE Study

Chest, 2013, Vol.144 (4), p.259A-259B

2013

Volltextzugriff (PDF)

675: CLINICAL EXPERIENCE WITH CEFTAROLINE FOSAMIL IN THE INTENSIVE CARE UNIT

Critical care medicine, 2016-12, Vol.44 (12 Suppl 1), p.245-245

2016

Volltextzugriff (PDF)

A Multicenter, Randomized, Observer-blinded, Active-controlled Study to Evaluate the Safety and Efficacy of Ceftaroline Versus Comparator in Pediatric Patients With Acute Bacterial Skin and Skin Structure Infection

The Pediatric infectious disease journal, 2016-08, Vol.35 (8), p.e239-e247

2016

Volltextzugriff (PDF)

A Multicenter, Randomized, Observer-blinded, Active-controlled Study Evaluating the Safety and Effectiveness of Ceftaroline Compared With Ceftriaxone Plus Vancomycin in Pediatric Patients With Complicated Community-acquired Bacterial Pneumonia

The Pediatric infectious disease journal, 2016-07, Vol.35 (7), p.760-766

2016

Volltextzugriff (PDF)

Lack of Effect of Rezafungin on QT/QTc Interval in Healthy Subjects

Clinical pharmacology in drug development, 2020-05, Vol.9 (4), p.456-465

2020

Volltextzugriff (PDF)

A Randomized, Prospective Study of Pediatric Patients With Community-acquired Pneumonia Treated With Ceftaroline Versus Ceftriaxone

The Pediatric infectious disease journal, 2016-07, Vol.35 (7), p.752-759

2016

Volltextzugriff (PDF)

CD101 Topical Compared With Oral Fluconazole for Acute Vulvovaginal Candidiasis: A Randomized Controlled Trial

Journal of lower genital tract disease, 2019-07, Vol.23 (3), p.226-229

2019

Volltextzugriff (PDF)

Population PK Modeling and Target Attainment Simulations to Support Dosing of Ceftaroline Fosamil in Pediatric Patients With Acute Bacterial Skin and Skin Structure Infections and Community‐Acquired Bacterial Pneumonia

Journal of clinical pharmacology, 2017-03, Vol.57 (3), p.345-355

2017

Volltextzugriff (PDF)

Efficacy of melaleuca oral solution for the treatment of fluconazole refractory oral candidiasis in AIDS patients

AIDS (London), 1998-06, Vol.12 (9), p.1033-1037

1998

Volltextzugriff (PDF)

982. Effect of Hepatic Impairment on the Safety and Pharmacokinetics of Rezafungin

Open forum infectious diseases, 2021-12, Vol.8 (Supplement_1), p.S582-S583

2021

Volltextzugriff (PDF)

Ceftaroline fosamil therapy in patients with acute bacterial skin and skin-structure infections with systemic inflammatory signs: A retrospective dose comparison across three pivotal trials

International journal of antimicrobial agents, 2019-06, Vol.53 (6), p.830-837

2019

Volltextzugriff (PDF)

1342. Comparison of Lysin CF-301 (Exebacase) Activity Against S. aureus Isolates From Bacteremic Patients Enrolled in a Phase 2 Study (CF-301-102) to Contemporary Surveillance Isolates

Open forum infectious diseases, 2018-11, Vol.5 (suppl_1), p.S410-S410

2018

Volltextzugriff (PDF)

Review of ceftaroline fosamil microbiology: integrated FOCUS studies

Journal of antimicrobial chemotherapy, 2011-04, Vol.66 Suppl 3 (Supplement 3), p.iii45-iii51

2011

Volltextzugriff (PDF)

Ceftaroline fosamil for treatment of diabetic foot infections: the CAPTURE study experience

Diabetes/metabolism research and reviews, 2015-05, Vol.31 (4), p.395-401

2015

Volltextzugriff (PDF)

Lysin CF-301 Demonstrates In Vitro Synergy with Conventional Antibiotics against Staphylococcus aureus

Open forum infectious diseases, 2017-10, Vol.4 (suppl_1), p.S370-S370

2017

Volltextzugriff (PDF)

2389. Effect of Rezafungin on QT Interval in Healthy Subjects

Open forum infectious diseases, 2018-11, Vol.5 (suppl_1), p.S712-S712

2018

Volltextzugriff (PDF)

Contemporary use of ceftaroline fosamil for the treatment of community-acquired bacterial pneumonia: CAPTURE study experience

Journal of chemotherapy (Florence), 2014-08, Vol.26 (4), p.229-234

2014

Volltextzugriff (PDF)

Community-Acquired Fungemia Due to a Multiple-Azole-Resistant Strain of Candida tropicalis

Clinical infectious diseases, 1999-12, Vol.29 (6), p.1583-1584

1999

Volltextzugriff (PDF)

Ceftaroline Fosamil for the Treatment of Staphylococcus aureus Bacteremia Secondary to Acute Bacterial Skin and Skin Structure Infections or Community-Acquired Bacterial Pneumonia

Infectious diseases in clinical practice (Baltimore, Md.), 2015-01, Vol.23 (1), p.39-43

2015

Volltextzugriff (PDF)

Ceftaroline fosamil and treatment of acute bacterial skin and skin structure infections: CAPTURE study experience

Journal of chemotherapy (Florence), 2013-12, Vol.25 (6), p.341-346

2013

Volltextzugriff (PDF)

1 – 25 von 33

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(33)
Mit Volltextzugriff
(21)

Publikationsform

Artikel
(32)
Tagungsberichte
(1)

Sprache

Englisch
(33)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(20)
Science & Technology
(20)
Humans
(15)
Ceftaroline
(14)
Male
(13)
Female
(12)
Infectious Diseases
(12)
Pharmacology & Pharmacy
(10)
Ceftaroline Fosamil
(9)
Cephalosporins - Administration & Dosage
(8)
Adult
(7)
Anti-Bacterial Agents - Administration & Dosage
(7)
Cephalosporins - Therapeutic Use
(7)
Immunology
(7)
Microbial Sensitivity Tests
(7)
Middle Aged
(7)
Treatment Outcome
(7)
Adolescent
(6)
Anti-Bacterial Agents - Adverse Effects
(6)
Anti-Bacterial Agents - Therapeutic Use
(6)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Effect of Ceftaroline on Normal Human Intestinal Microflora

Penetration of Ceftaroline into the Epithelial Lining Fluid of Healthy Adult Subjects

Phase I study of the pharmacokinetics and safety of rezafungin in subjects with moderate/severe hepatic impairment and matched control subjects

679: Effect of Moderate Hepatic Impairment on the Safety and Pharmacokinetics of Rezafungin

Dalbavancin for the Treatment of Osteomyelitis in Adult Patients: A Randomized Clinical Trial of Efficacy and Safety

Current Use of Ceftaroline for Community-Acquired Bacterial Pneumonia (CABP) in US Hospitals: Length of Stay and Total Cost From the CAPTURE Study

675: CLINICAL EXPERIENCE WITH CEFTAROLINE FOSAMIL IN THE INTENSIVE CARE UNIT

A Multicenter, Randomized, Observer-blinded, Active-controlled Study to Evaluate the Safety and Efficacy of Ceftaroline Versus Comparator in Pediatric Patients With Acute Bacterial Skin and Skin Structure Infection

A Multicenter, Randomized, Observer-blinded, Active-controlled Study Evaluating the Safety and Effectiveness of Ceftaroline Compared With Ceftriaxone Plus Vancomycin in Pediatric Patients With Complicated Community-acquired Bacterial Pneumonia

Lack of Effect of Rezafungin on QT/QTc Interval in Healthy Subjects

A Randomized, Prospective Study of Pediatric Patients With Community-acquired Pneumonia Treated With Ceftaroline Versus Ceftriaxone

CD101 Topical Compared With Oral Fluconazole for Acute Vulvovaginal Candidiasis: A Randomized Controlled Trial

Population PK Modeling and Target Attainment Simulations to Support Dosing of Ceftaroline Fosamil in Pediatric Patients With Acute Bacterial Skin and Skin Structure Infections and Community‐Acquired Bacterial Pneumonia

Efficacy of melaleuca oral solution for the treatment of fluconazole refractory oral candidiasis in AIDS patients

982. Effect of Hepatic Impairment on the Safety and Pharmacokinetics of Rezafungin

Ceftaroline fosamil therapy in patients with acute bacterial skin and skin-structure infections with systemic inflammatory signs: A retrospective dose comparison across three pivotal trials

1342. Comparison of Lysin CF-301 (Exebacase) Activity Against S. aureus Isolates From Bacteremic Patients Enrolled in a Phase 2 Study (CF-301-102) to Contemporary Surveillance Isolates

Review of ceftaroline fosamil microbiology: integrated FOCUS studies

Ceftaroline fosamil for treatment of diabetic foot infections: the CAPTURE study experience

Lysin CF-301 Demonstrates In Vitro Synergy with Conventional Antibiotics against Staphylococcus aureus

2389. Effect of Rezafungin on QT Interval in Healthy Subjects

Contemporary use of ceftaroline fosamil for the treatment of community-acquired bacterial pneumonia: CAPTURE study experience

Community-Acquired Fungemia Due to a Multiple-Azole-Resistant Strain of Candida tropicalis

Ceftaroline Fosamil for the Treatment of Staphylococcus aureus Bacteremia Secondary to Acute Bacterial Skin and Skin Structure Infections or Community-Acquired Bacterial Pneumonia

Ceftaroline fosamil and treatment of acute bacterial skin and skin structure infections: CAPTURE study experience

Suchergebnisse filtern